Literature DB >> 27845239

Circuit dysregulation and circuit-based treatments in posttraumatic stress disorder.

Jony Sheynin1, Israel Liberzon2.   

Abstract

Posttraumatic stress disorder (PTSD) is a psychiatric disorder that develops in some individuals in the aftermath of exposure to traumatic events, such as actual or threatened death, serious injury or sexual assault. It has been hypothesized that dysregulations in a number of specific neurocircuits, characterized by heightened responsivity of amygdala, dACC and insula, diminished responsivity of mPFC, impaired hippocampal function and deficits in cortical regions, underlie the development and expression of key PTSD symptoms. Here, we concisely describe three functional neural circuits implicated in PTSD pathophysiology and briefly review selected treatment strategies in the context of these neural circuits. We start with the commonly implicated neurocircuit model, namely, the fear learning and threat detection circuits, and then discuss the context processing circuitry, which plays an important role among others, in fear regulation. We then discuss the emotion regulation circuitry, which can further contribute to PTSD pathophysiology, and conclude with a discussion of the therapeutic approaches that might be targeting dysregulation in these circuits in PTSD patients. Specifically, we discuss how exposure-based treatments might be targeting fear learning circuits, and the pharmacological and brain-stimulation interventions aimed to augment these therapies. Finally, we discuss other pharmacological and cognitive therapeutic approaches that can augment or restore the function of the context processing and emotional regulation circuits.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Circuit dysregulation; Circuit- based treatments; Posttraumatic stress disorder

Mesh:

Year:  2016        PMID: 27845239      PMCID: PMC5422122          DOI: 10.1016/j.neulet.2016.11.014

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  80 in total

Review 1.  Amygdala, medial prefrontal cortex, and hippocampal function in PTSD.

Authors:  Lisa M Shin; Scott L Rauch; Roger K Pitman
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

2.  Learning, memory and brain plasticity in posttraumatic stress disorder: context matters.

Authors:  Herta Flor; Frauke Nees
Journal:  Restor Neurol Neurosci       Date:  2014       Impact factor: 2.406

Review 3.  Changing fear: the neurocircuitry of emotion regulation.

Authors:  Catherine A Hartley; Elizabeth A Phelps
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

4.  History of Mindfulness-Based Cognitive Therapy Is Associated with Increased Cognitive Reappraisal Ability.

Authors:  Allison S Troy; Amanda J Shallcross; Tchiki S Davis; Iris B Mauss
Journal:  Mindfulness (N Y)       Date:  2013-09-01

5.  Emotion Regulatory Brain Function and SSRI Treatment in PTSD: Neural Correlates and Predictors of Change.

Authors:  Annmarie MacNamara; Christine A Rabinak; Amy E Kennedy; Daniel A Fitzgerald; Israel Liberzon; Murray B Stein; K Luan Phan
Journal:  Neuropsychopharmacology       Date:  2015-06-26       Impact factor: 7.853

Review 6.  The neurocircuitry of fear, stress, and anxiety disorders.

Authors:  Lisa M Shin; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 7.  Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.

Authors:  Natalie Katalinic; Rosalyn Lai; Andrew Somogyi; Philip B Mitchell; Paul Glue; Colleen K Loo
Journal:  Aust N Z J Psychiatry       Date:  2013-05-09       Impact factor: 5.744

8.  Neural dysregulation in posttraumatic stress disorder: evidence for disrupted equilibrium between salience and default mode brain networks.

Authors:  Rebecca K Sripada; Anthony P King; Robert C Welsh; Sarah N Garfinkel; Xin Wang; Chandra S Sripada; Israel Liberzon
Journal:  Psychosom Med       Date:  2012-10-31       Impact factor: 4.312

9.  Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors.

Authors:  Maria Anne Briscione; Tanja Jovanovic; Seth Davin Norrholm
Journal:  Front Psychiatry       Date:  2014-07-21       Impact factor: 4.157

10.  Emotion regulation, physiological arousal and PTSD symptoms in trauma-exposed individuals.

Authors:  Laura Shepherd; Jennifer Wild
Journal:  J Behav Ther Exp Psychiatry       Date:  2014-03-26
View more
  26 in total

1.  Regulator of G protein signaling 14 (RGS14) is expressed pre- and postsynaptically in neurons of hippocampus, basal ganglia, and amygdala of monkey and human brain.

Authors:  Katherine E Squires; Kyle J Gerber; Jean-Francois Pare; Mary Rose Branch; Yoland Smith; John R Hepler
Journal:  Brain Struct Funct       Date:  2017-08-03       Impact factor: 3.270

2.  Default mode network abnormalities in posttraumatic stress disorder: A novel network-restricted topology approach.

Authors:  Teddy J Akiki; Christopher L Averill; Kristen M Wrocklage; J Cobb Scott; Lynnette A Averill; Brian Schweinsburg; Aaron Alexander-Bloch; Brenda Martini; Steven M Southwick; John H Krystal; Chadi G Abdallah
Journal:  Neuroimage       Date:  2018-05-03       Impact factor: 6.556

3.  Theta-Burst Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder.

Authors:  Noah S Philip; Jennifer Barredo; Emily Aiken; Victoria Larson; Richard N Jones; M Tracie Shea; Benjamin D Greenberg; Mascha van 't Wout-Frank
Journal:  Am J Psychiatry       Date:  2019-06-24       Impact factor: 18.112

4.  Increased recruitment of cognitive control in the presence of traumatic stimuli in complex PTSD.

Authors:  Julia I Herzog; Inga Niedtfeld; Sophie Rausch; Janine Thome; Meike Mueller-Engelmann; Regina Steil; Kathlen Priebe; Martin Bohus; Christian Schmahl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-15       Impact factor: 5.270

5.  Disturbed effective connectivity patterns in an intrinsic triple network model are associated with posttraumatic stress disorder.

Authors:  Yifei Weng; Rongfeng Qi; Li Zhang; Yifeng Luo; Jun Ke; Qiang Xu; Yuan Zhong; Jianjun Li; Feng Chen; Zhihong Cao; Guangming Lu
Journal:  Neurol Sci       Date:  2018-11-17       Impact factor: 3.307

Review 6.  Should Posttraumatic Stress Be a Disorder or a Specifier? Towards Improved Nosology Within the DSM Categorical Classification System.

Authors:  Jeffrey Guina; Matthew Baker; Kelly Stinson; Jon Maust; Joseph Coles; Pamela Broderick
Journal:  Curr Psychiatry Rep       Date:  2017-08-15       Impact factor: 5.285

Review 7.  A Network-Based Neurobiological Model of PTSD: Evidence From Structural and Functional Neuroimaging Studies.

Authors:  Teddy J Akiki; Christopher L Averill; Chadi G Abdallah
Journal:  Curr Psychiatry Rep       Date:  2017-09-19       Impact factor: 5.285

8.  Locus Coeruleus Phasic, But Not Tonic, Activation Initiates Global Remapping in a Familiar Environment.

Authors:  Stephanie L Grella; Jonathan M Neil; Hilary T Edison; Vanessa D Strong; Irina V Odintsova; Susan G Walling; Gerard M Martin; Diano F Marrone; Carolyn W Harley
Journal:  J Neurosci       Date:  2018-11-26       Impact factor: 6.167

9.  Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice.

Authors:  Leah M Mayo; Anna Asratian; Johan Lindé; Lovisa Holm; Daniel Nätt; Gaëlle Augier; Niclas Stensson; Haley A Vecchiarelli; Georgia Balsevich; Robert J Aukema; Bijar Ghafouri; Primavera A Spagnolo; Francis S Lee; Matthew N Hill; Markus Heilig
Journal:  Mol Psychiatry       Date:  2018-08-17       Impact factor: 15.992

10.  Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence.

Authors:  Agnes Norbury; Sarah B Rutter; Abigail B Collins; Sara Costi; Manish K Jha; Sarah R Horn; Marin Kautz; Morgan Corniquel; Katherine A Collins; Andrew M Glasgow; Jess Brallier; Lisa M Shin; Dennis S Charney; James W Murrough; Adriana Feder
Journal:  Neuropsychopharmacology       Date:  2021-07-31       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.